KATKIN KEITH sold 13.9% of their position (15.48K shares) of EMERGENT BIOSOLUTIONS INC. on the open market
Open‑market sale worth $128.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/4/2026ACC: 0001314596-26-000002
+21.16K
Net shares
Net buyer
$128.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
36.64K acquired · 15.48K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25.34K
Price / share
—
Trade value
—
% of position
29.3%
4/30/2026
86.43K→111.78K
Common Stock
Direct
Shares
−15.48K
Price / share
$8.28
Trade value
$128.18K
% of position
13.9%
4/30/2026
111.78K→96.29K
Total
Net shares
+9.86K
Net value
-$128.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/30/2026 | A · Award | +25.34K | — | — | 29.3% | 86.43K | 111.78K |
| Common Stock Direct | 4/30/2026 | S · Sale | −15.48K | $8.28 | $128.18K | 13.9% | 111.78K | 96.29K |
| Total | +9.86K | -$128.18K | ||||||
Derivative Transactions1
Stock Options (Right to Buy)
Direct
Converts to
Common Stock
11.30K shares
Shares
+11.30K
Strike price
7.99
Held after
11.30K
Exercisable
—
4/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock11.30K shares | 4/30/2026 | A · Award | +11.30K | 7.99 | — | 11.30K |